Synapsee Remedies Private Limited
About Synapsee Remedies Private Limited
Data last updated:
Synapsee Remedies Private Limited is a private limited company based in Nanded, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 03 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U74999MH2017PTC293375. Its GSTIN is 27AAYCS4522L2ZL (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹16 Lakh. It is led by directors including Aishwarya Satish Waigaonkar and Sagar Sudhakar Rahegaonkar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No D – 52/1 MIDC, Nanded, Maharashtra, India – 431603.
As per the financials filed for FY 2023, the company reported a revenue of ₹12.49 Lakh, a decline of 57% compared to the previous year. For the same year it recorded a net profit of ₹1,352 (net margin 0.1%) and EBITDA of ₹4,345 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Synapsee Remedies Private Limited's registered office is in Nanded, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No D – 52/1 MIDC, Nanded, Maharashtra, India – 431603
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Synapsee Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synapsee Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Synapsee Remedies Private Limited, buy the company report.
Financials of Synapsee Remedies Private Limited
FY 2023 filings availableSynapsee Remedies Private Limited reported revenue of ₹12.49 Lakh (down 57% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 57% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,345 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,352 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synapsee Remedies Private Limited, buy the company report.
Board of directors of Synapsee Remedies Private Limited
Synapsee Remedies has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aishwarya Satish Waigaonkar Also directs: Waiko Drugs and Pharma LLP | Director | 10 May 2019 | 7 Years 6 Months | Current |
| Sagar Sudhakar Rahegaonkar | Director | 03 Apr 2017 | 9 Years 7 Months | Current |
| Subodh Gaikwad Pandurang | Director | 03 Apr 2017 | 9 Years 7 Months | Current |
| Vinayak Kanakdande | Director | 03 Apr 2017 | 9 Years 7 Months | Current |
Peer comparison
Synapsee Remedies Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mitula Pharmaceuticals Private Limited | ₹12.55 Lakh (FY 2025) | -54.0% | Mumbai, Maharashtra, India | |||
| Oxide(India) Catalysts Pvt Ltd | ₹12.54 Lakh (FY 2018) | -74.0% | Durgapur, West Bengal, India | |||
| Dolce Pharmaceuticals Private Limited | ₹12.5 Lakh (FY 2019) | 145285.0% | Boisar, Maharashtra, India | |||
| Rajyoti Remedies Private Limited | ₹12.5 Lakh (FY 2024) | -17.0% | Bihar, India | |||
| Nakshi Biosciences Private Limited | ₹12.5 Lakh (FY 2025) | 48.0% | Ahmedabad, Gujarat, India | |||
| Synapsee Remedies Private Limitedthis company | ₹12.49 Lakh (FY 2023) | ₹1,352 | 0.1% | -57.0% | Nanded, Maharashtra, India | |
| Careway Ayu Private Limited | ₹12.49 Lakh (FY 2024) | 114.0% | Dehgam, Gujarat, India | |||
| Healcoans Private Limited | ₹12.46 Lakh (FY 2021) | -56.0% | Jalgaon, Maharashtra, India | |||
| Far Out Sciences Private Limited | ₹12.46 Lakh (FY 2025) | 714.0% | Gurgaon, Haryana, India | |||
| Orga Creaation Private Limited | ₹12.46 Lakh (FY 2018) | Kolhapur, Maharashtra, India | ||||
| Shypram Pharmaceuticals Private Limited | ₹12.46 Lakh (FY 2021) | -49.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Synapsee Remedies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Synapsee Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synapsee Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Synapsee Remedies has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAYCS4522L2ZL | Maharashtra | Active | 16 Aug 2017 |
To see the full GST registrations and return filing status of Synapsee Remedies Private Limited, buy the company report.
Recent activity
Synapsee Remedies Private Limited has 5 board changes on record since 2017: 4 appointments and 1 cessation. The latest: Aishwarya Satish Waigaonkar was appointed as Director on 10 May 2019.
Frequently asked questions
Synapsee Remedies is an active private limited company based in Nanded, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 03 April 2017 (9+ years old) and is registered under CIN U74999MH2017PTC293375.
Synapsee Remedies has 4 current directors:
- Aishwarya Satish Waigaonkar - Director
- Sagar Sudhakar Rahegaonkar - Director
- Subodh Gaikwad Pandurang - Director
- Vinayak Kanakdande - Director
The latest financial statements of Synapsee Remedies on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Synapsee Remedies is 27AAYCS4522L2ZL, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Synapsee Remedies is U74999MH2017PTC293375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synapsee Remedies was incorporated on 03 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Synapsee Remedies by revenue are Mitula Pharmaceuticals Private Limited, Oxide(India) Catalysts Pvt Ltd, Dolce Pharmaceuticals Private Limited, Rajyoti Remedies Private Limited, Nakshi Biosciences Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aishwarya Satish Waigaonkar was appointed as Director on 10 May 2019. Satish Waigaonkar Ramchandra ceased to be Director on 10 May 2019. Sagar Sudhakar Rahegaonkar was appointed as Director on 03 Apr 2017. Synapsee Remedies has 5 board changes on record in total.
The registered office of Synapsee Remedies is at Plot No D – 521 MIDC, Nanded, Maharashtra, India – 431603.
Synapsee Remedies operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Synapsee Remedies is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
